As CHST11 is a key enzyme for glycosaminoglycan sulfation, these results suggest CHST11+ naive T cells in pancreatic cancer may have "Th2 differentiation tendency" and promote T cell exhaustion by enhancing apoptosis sensitivity via the FAS/FASLG pathway. Here, FASLG is linked to pancreatic neoplasm.